Smiths Group (LON:SMIN) Price Target Raised to GBX 1,580

Smiths Group (LON:SMIN) had its price objective raised by Goldman Sachs Group from GBX 1,520 ($18.71) to GBX 1,580 ($19.44) in a research report report published on Tuesday, Stock Target Advisor reports. The brokerage currently has a buy rating on the stock.

Several other research firms also recently weighed in on SMIN. Barclays reissued an overweight rating on shares of Smiths Group in a research report on Monday, May 18th. Citigroup reiterated a buy rating on shares of Smiths Group in a research report on Tuesday, April 7th. JPMorgan Chase & Co. cut their target price on shares of Smiths Group from GBX 1,875 ($23.07) to GBX 1,300 ($16.00) and set an overweight rating on the stock in a research note on Wednesday, March 25th. Royal Bank of Canada raised Smiths Group to an outperform rating and decreased their target price for the stock from GBX 1,690 ($20.80) to GBX 1,300 ($16.00) in a research report on Thursday, March 19th. Finally, Liberum Capital reissued a hold rating on shares of Smiths Group in a research report on Tuesday. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus price target of GBX 1,482.86 ($18.25).

Shares of SMIN opened at GBX 1,387 ($17.07) on Tuesday. The business’s 50-day moving average price is GBX 1,300.26 and its 200 day moving average price is GBX 1,418.12. The company has a current ratio of 2.76, a quick ratio of 0.92 and a debt-to-equity ratio of 66.83. The stock has a market capitalization of $5.15 billion and a P/E ratio of 22.09. Smiths Group has a 1-year low of GBX 790 ($9.72) and a 1-year high of GBX 2,246.40 ($27.64).

In other news, insider George Buckley purchased 1,029 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was bought at an average cost of GBX 1,215 ($14.95) per share, with a total value of £12,502.35 ($15,385.61).

Smiths Group Company Profile

Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.

Read More: What are the advantages to having securities held in street name?

Analyst Recommendations for Smiths Group (LON:SMIN)

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with's FREE daily email newsletter.